Of the 183 melanoma patients in the ICGC cohort, the significantly high TML was also observed in patients with MUC16 mutations (median TML: 4.63 vs. 1.01; Wilcoxon rank sum test, P < 0.001; Figure 2B). The gene discussed is MUC16; the disease is melanoma.